English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

years of treatment with TCZ. Disclosure statement: N.R. has been involved in a speakers’ bureau for AstraZeneca, Bristol-Myers Squibb, Janssen Biologics B.V., Roche, Wyeth and Pfizer; and has received a research grant to Gaslini Hospital from Abbott, AstraZeneca, BMS, Centocor Research & Development, Eli Lilly and Company, Novartis, Pfizer Inc., Roche, Sanofi Aventis, Schwarz Biosciences GmbH, Xoma and Wyeth. H.I.B. has received a consultancy payment from Novartis, Genentech, Medimmune, EMD Serono, AMS, Pfizer, UCB and Janssen; and has been involved in a speakers’ bureau for Genentech. R.C. has been involved in a speakers’ bureau for Roche, Abbott, Pfizer, Novartis and BMS. J.W. is an employee of Roche. C.D. is an employee of Roche. D.J.L. has received a consultancy payment from AstraZeneca, Centocor, Janssen, Wyeth, Amgen, Bristol-Meyers Squibb, Abbott, Pfizer, Regeneron, Hoffmann-La Roche, Novartis and Genentech; has been involved in a speakers’ bureau for Roche and Genentech; and has received a research grant from NIH. A.M. has received a consultancy payment from Abbott, AstraZeneca, BMS, Centocor, Lilly, Francesco Angelini, GSK, Italfarmaco, Merck Serono, Novartis, Pfizer, Regeneron, Roche, Sanofi Aventis, Schwarz Biosciences, Xoma and Wyeth; has been involved in a speakers’ bureau for Abbott, Boehringer, BMS, Novartis, Astellas, Italfarmaco, MedImmune, Pfizer and Roche; and has received a research grant from Abbott, AstraZeneca, BMS, Centocor, Lilly, Francesco Angelini, GSK, Italfarmaco, Merck Serono, Novartis, Pfizer, Regeneron, Roche, Sanofi Aventis, Schwarz Biosciences, Xoma and Wyeth. F.D.B. has received a research grant from Abbott, Pfizer, BMS, Roche, Novimmune, Novartis and SOBI. All other authors have declared no conflicts of interest.

290. Being as Normal as Possible: How Young People Value the Risks and Benefits of Treatment